Spirostanyl glycosidal crystalline monohydrate
US5760009A · kind A · utility
5Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1995 |
| Grant date | Jun 2, 1998 |
| Priority date | — |
| Expiry date | Oct 19, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A crystalline monohydrate of (3.beta.,5.alpha.,25R)-3-(.beta.-D-cellobiosyl)oxy!spirostan-11-one that is useful as a hypocholesterolemic or antiatherosclerosis agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.